论文部分内容阅读
探讨大肠癌肝转移病人的生存与相关因素之间的关系。我们对５０例大肠癌肝转移病人的临床因素，生存质量，肿瘤大小，血清碱性磷酸酶和体重进行评估。体质症状评分是一个较ＣＴ扫描测量肿瘤大小更精确的生存预告者，预测生存的最好模型包括腹泻、进食、休息、工作能力和睡眠等生活质量问题。唯一临床测量变量（包括在这个最好生存预告模型里）是血清碱性磷酸酶水平，研究展示生活质量能预测大肠癌肝转移的生存。肿瘤产物和肿瘤大小的差异能影响病人的健康和大肠癌的生存，通过生活质量评估这些差异较肿瘤大小的测量更为精确。大肠癌肝转移病人的生存与临床因素、生活质量、血清碱性磷酸酶呈正相关系，而与肿瘤大小，体重减轻不呈正相关系。
To explore the relationship between survival and related factors in patients with colorectal liver metastases. We evaluated the clinical factors, quality of life, tumor size, serum alkaline phosphatase and body weight in 50 patients with colorectal liver metastases. The physical symptom score is a more accurate survival predictor than the CT scan measurement of tumor size. The best predictors of survival include diarrhea, eating, rest, work ability and sleep quality of life issues. The only clinical measurement variable (included in this best survival prediction model) is serum alkaline phosphatase, and studies have shown that quality of life can predict the survival of colorectal liver metastases. Differences in tumor product and tumor size can affect patient health and colorectal cancer survival. These differences are more accurately measured by quality of life than tumor size measurements. The survival of patients with colorectal liver metastases was positively correlated with clinical factors, quality of life, and serum alkaline phosphatase, but not with the tumor size and weight loss.